Moreover, BChE is implicated in the aggregation of amyloid-beta peptides, a hallmark of AD pathology, and the selective inhibition of BChE may reduce amyloid-beta toxicity, providing an additional therapeutic benefit [4]. The gene discussed is BCHE; the disease is Alzheimer disease.